To address this knowledge gap, we conducted a retrospective cohort study to assess the clinical impact of combination therapy compared to SGLT2i monotherapy in patients with MASLD
He, L., Li, Q., Yang, Y., Li, J., Luo, W., Huang, Y., & Zhong, X
Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial
by contrast, U0126, an inhibitor of MAPK kinases, suppressed PFOS-mediated IRE1 overexpression, suggesting that ER stress is a downstream target of the ERK pathway (Fig
MD and docking studies reveal that the functional switch of CYFIP1 is mediated by a butterfly-like motion
Development of human pluripotent stem cell-derived hepatic organoids as an alternative model for drug safety assessment